ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MIGUEL STUBBS M.D.

Internal Medicine

67,780

$4.02M

1145
933 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$59
Average prescription price

Avg: $56

JOHN ARNETT M.D.

Internal Medicine

54,045

$2.84M

1528
997 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$53
Average prescription price

Avg: $56

GEORGE PURSLEY MD

Internal Medicine

46,881

$2.55M

1386
1046 are 65+

25%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

ASHOK KANCHARLA M.D.

Internal Medicine

45,670

$2.09M

943
603 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

43%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

DAVID KAVTARADZE M.D.

Internal Medicine

44,656

$3.06M

1002
718 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 26%

$69
Average prescription price

Avg: $56

JEAN SUMNER M.D.

Internal Medicine

42,843

$2.4M

881
763 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

JAMES COCHRAN M.D.

Internal Medicine

40,327

$1.46M

1245
989 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $56

GUIDO RING MD

Internal Medicine

40,028

$2.09M

841
610 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$52
Average prescription price

Avg: $56

JOHN HILL MD

Internal Medicine

38,386

$1.73M

1121
855 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

JOSEPH THOMAS MD

Internal Medicine

36,755

$1.66M

980
755 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

GALINA VAYNER MD

Internal Medicine

36,387

$2.17M

818
762 are 65+

1%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 26%

$60
Average prescription price

Avg: $56

HARRISON CARTER MD

Internal Medicine

34,488

$1.51M

887
677 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

DEAN TALLEY M.D.

Internal Medicine

34,107

$1.57M

850
580 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

ROBERT KAUFMANN M.D.

Internal Medicine

33,413

$2.14M

1514
1238 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 26%

$64
Average prescription price

Avg: $56

JAMES SEXSON M.D.

Internal Medicine

32,976

$2.2M

809
641 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$67
Average prescription price

Avg: $56

SUSAN HARDING MD

Internal Medicine

32,785

$1.54M

882
367 are 65+

21%
patients receiving schedule two controlled substances

Avg: 3%

57%
patients receiving schedule three controlled substances

Avg: 11%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

MARIA ACOSTA M.D.

Internal Medicine

32,645

$1.55M

1080
651 are 65+

2%
patients receiving schedule two controlled substances

Avg: 3%

27%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

DAVID VANN M.D.

Internal Medicine

32,459

$1.26M

931
728 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$39
Average prescription price

Avg: $56

BENJAMIN WILLIAMS MD

Internal Medicine

32,412

$1.35M

957
819 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$42
Average prescription price

Avg: $56

ROBERT PUMPELLY MD

Internal Medicine

31,987

$1.56M

766
629 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

AZHAR NISAR MD

Internal Medicine

30,538

$1.57M

544
317 are 65+

15%
patients receiving schedule two controlled substances

Avg: 3%

44%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $56

APPAVUCHETTY SOUNDAPPAN MD

Internal Medicine

30,170

$1.44M

620
478 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

30%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

CHELUKALA REDDY M.D.

Internal Medicine

30,125

$1.14M

645
373 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

53%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

ARNOLD SMALLS MD

Internal Medicine

30,038

$1.41M

1219
825 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

21%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $56

ANTHONY HOWARD M.D.

Internal Medicine

29,913

$1.48M

543
345 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

41%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$50
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank